View in EDS HTML Full Text PDF Full Text

Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study.
Authors: Anders HJ; Division of Nephrology, Department of Medicine IV, Hospital of the Ludwig-Maximilians University, Munich, Germany., Chan TM; Department of Medicine, School of Clinical Medicine at the University of Hong Kong, Hong Kong, China., Sanchez-Guerrero J; Departmento de Inmunología y Reumatología, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.; Sinai Health System and University Health Network, Division of Rheumatology, University of Toronto, Toronto, ON, Canada., Wofsy D; University of California San Francisco, San Francisco, CA, USA., Bensley K; Janssen Research & Development, LLC, Spring House, PA, USA., Kim L; Janssen Research & Development, LLC, Spring House, PA, USA., Lo KH; Janssen Research & Development, LLC, Spring House, PA, USA., Shu C; Janssen Research & Development, LLC, Spring House, PA, USA., Shao J; Janssen Research & Development, LLC, Spring House, PA, USA., Karyekar CS; Janssen Research & Development, LLC, Spring House, PA, USA., Diamond B; The Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2025 May 01; Vol. 64 (5), pp. 2731-2740.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39673415
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Anders+HJ%22">Anders HJ</searchLink>; Division of Nephrology, Department of Medicine IV, Hospital of the Ludwig-Maximilians University, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Chan+TM%22">Chan TM</searchLink>; Department of Medicine, School of Clinical Medicine at the University of Hong Kong, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Sanchez-Guerrero+J%22">Sanchez-Guerrero J</searchLink>; Departmento de Inmunología y Reumatología, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.; Sinai Health System and University Health Network, Division of Rheumatology, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Wofsy+D%22">Wofsy D</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bensley+K%22">Bensley K</searchLink>; Janssen Research & Development, LLC, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+L%22">Kim L</searchLink>; Janssen Research & Development, LLC, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lo+KH%22">Lo KH</searchLink>; Janssen Research & Development, LLC, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Shu+C%22">Shu C</searchLink>; Janssen Research & Development, LLC, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Shao+J%22">Shao J</searchLink>; Janssen Research & Development, LLC, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Karyekar+CS%22">Karyekar CS</searchLink>; Janssen Research & Development, LLC, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Diamond+B%22">Diamond B</searchLink>; The Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883501%22">Rheumatology (Oxford, England)</searchLink> [Rheumatology (Oxford)] 2025 May 01; Vol. 64 (5), pp. 2731-2740.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883501 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1462-0332 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214620324%22">14620324 </searchLink><i>NLM ISO Abbreviation: </i>Rheumatology (Oxford) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39673415
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/rheumatology/keae647
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2731
    Titles:
      – TitleFull: Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Anders HJ
      – PersonEntity:
          Name:
            NameFull: Chan TM
      – PersonEntity:
          Name:
            NameFull: Sanchez-Guerrero J
      – PersonEntity:
          Name:
            NameFull: Wofsy D
      – PersonEntity:
          Name:
            NameFull: Bensley K
      – PersonEntity:
          Name:
            NameFull: Kim L
      – PersonEntity:
          Name:
            NameFull: Lo KH
      – PersonEntity:
          Name:
            NameFull: Shu C
      – PersonEntity:
          Name:
            NameFull: Shao J
      – PersonEntity:
          Name:
            NameFull: Karyekar CS
      – PersonEntity:
          Name:
            NameFull: Diamond B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1462-0332
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Rheumatology (Oxford, England)
              Type: main
ResultId 1